These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23641042)

  • 21. Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review.
    Préaud E; Largeron N
    J Med Econ; 2013; 16(6):763-76. PubMed ID: 23565814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlates of human papillomavirus vaccine coverage: a state-level analysis.
    Moss JL; Reiter PL; Brewer NT
    Sex Transm Dis; 2015 Feb; 42(2):71-5. PubMed ID: 25585064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.
    Gomez JA; Lepetic A; Demarteau N
    BMC Public Health; 2014 Nov; 14():1222. PubMed ID: 25424716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burden and incidence of human papillomavirus-associated cancers and precancerous lesions in Denmark.
    Svahn MF; Munk C; von Buchwald C; Frederiksen K; Kjaer SK
    Scand J Public Health; 2016 Aug; 44(6):551-9. PubMed ID: 27289104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country.
    Burger EA; Campos NG; Sy S; Regan C; Kim JJ
    Vaccine; 2018 Aug; 36(32 Pt A):4823-4829. PubMed ID: 29807710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost-effectiveness of male HPV vaccination in the United States.
    Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
    Vaccine; 2011 Oct; 29(46):8443-50. PubMed ID: 21816193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of cancers with human papillomavirus vaccination.
    CA Cancer J Clin; 2016 Sep; 66(5):386. PubMed ID: 27434855
    [No Abstract]   [Full Text] [Related]  

  • 29. Disease burden of human papillomavirus infection in the Netherlands, 1989-2014: the gap between females and males is diminishing.
    McDonald SA; Qendri V; Berkhof J; de Melker HE; Bogaards JA
    Cancer Causes Control; 2017 Mar; 28(3):203-214. PubMed ID: 28213874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.
    Vetter KM; Geller SE
    J Womens Health (Larchmt); 2007 Nov; 16(9):1258-68. PubMed ID: 18001182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus vaccine update.
    Gilmer LS
    Prim Care; 2015 Mar; 42(1):17-32. PubMed ID: 25634702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia.
    Smith MA; Lew JB; Walker RJ; Brotherton JM; Nickson C; Canfell K
    Vaccine; 2011 Nov; 29(48):9112-22. PubMed ID: 21419773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytology and DNA HPV-testing in the era of HPV-vaccine].
    Spaczyński M; Malkowska-Walczak B; Nowak-Markwitz E
    Ginekol Pol; 2007 Sep; 78(9):696-700. PubMed ID: 18159823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus infection among young adolescents in India: impact of vaccination.
    Hussain S; Bharadwaj M; Nasare V; Kumari M; Sharma S; Hedau S; Das BC
    J Med Virol; 2012 Feb; 84(2):298-305. PubMed ID: 22170551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus vaccines.
    Satyaprakash A; Creed R; Ravanfar P; Mendoza N
    Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Papillomavirus Infection and Vaccination.
    Valentino K; Poronsky CB
    J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing the health burden of HPV infection through vaccination.
    Soper D
    Infect Dis Obstet Gynecol; 2006; 2006 Suppl():83084. PubMed ID: 16967913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial: HPV vaccination: preventing more cancers in future generations.
    Kelly D
    J Clin Nurs; 2014 Apr; 23(7-8):909-10. PubMed ID: 24606392
    [No Abstract]   [Full Text] [Related]  

  • 39. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.
    Gertig DM; Brotherton JM; Saville M
    Sex Health; 2011 Jun; 8(2):171-8. PubMed ID: 21592430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus vaccination in HIV-infected women: need for increased coverage.
    Kojic EM; Rana AI; Cu-Uvin S
    Expert Rev Vaccines; 2016; 15(1):105-17. PubMed ID: 26599305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.